SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

BlackRock Files Schedule 13G/A for Kymera Therapeutics

A Schedule 13G/A for Kymera Therapeutics was filed by BlackRock, Inc.

KYMR

Related stories